News

31 August 2018
medwireNews: Very young children with Prader–Willi syndrome continue to accrue mental and motor development benefits during 3 years of treatment with growth hormone (GH), say researchers. Stephany Donze (Dutch Growth Research Foundation, Rotterdam) and colleagues previously found that 1 year of GH treatment improved these outcomes in a... Read More
31 August 2018
medwireNews: Impaired glucose tolerance in obese youths frequently reverts to normal, although the chances of this happening are strongly influenced by ethnicity, researchers report in The Lancet Child & Adolescent Health. However, reverting to normal glucose tolerance was associated with a significant increase in the oral... Read More
31 August 2018
medwireNews: The SYNERGY trial investigators report significant improvements in height velocity in South Korean children with idiopathic short stature (ISS) treated with daily recombinant human growth hormone (rhGH). During the first 6 months of treatment, the average height velocity increased from 5.63 cm/year to 10.08 cm/year in 59 children... Read More
31 July 2018
medwireNews: The Endocrine Society has released a guideline for the diagnosis and treatment of hypothalamic–pituitary and growth disorders in survivors of childhood cancer. Charles Sklar (Memorial Sloan-Kettering Cancer Center, New York, USA) and guideline co-authors note that 40–50% of childhood cancer survivors “will develop at least one... Read More
31 July 2018
medwireNews: Patients with Silver–Russell syndrome experience issues with their appearance and with social interactions, as well as with their height, show findings from an interview-based study. Lisa Marie Ballard (University of Southampton, UK) and colleagues interviewed 15 patients with Silver–Russell syndrome – all adults at the time –... Read More
31 July 2018
medwireNews: Real-time data on treatment adherence show its importance for good growth outcomes in patients taking recombinant human growth hormone (GH). Ekaterina Koledova (Merck Serono SA, Darmstadt, Germany) and colleagues made use of data from 1190 patients in the easypod™ connect observational study (ECOS), a register of patients using... Read More